Dr. Debra Patt

Debra Patt, an oncology leader and chair of ASCO's AI task force, joins Doug Flora, a community oncology expert, to dive into the transformative effects of AI in cancer care. They discuss the barriers to AI adoption, emphasizing that change management is more critical than the technology itself. The pair also tackle Medicare's AI policies, the importance of clinical decision support, and the need for diverse training data to address bias. Their insights spotlight the balance between innovation and patient safety in a rapidly evolving healthcare landscape.

Dr. Debra Patt, a prominent breast oncologist and leader at Texas Oncology, shares her insights on the transformative role of AI in modern healthcare. She discusses how AI enhances cancer diagnostics, treatment decisions, and patient education. The conversation delves into AI's impact on drug discovery, improving clinical trial efficiency, and reducing costs. They also highlight the need for collaboration between clinicians and technology while addressing data integration challenges and ethical considerations in AI usage, emphasizing personalized patient care.

Join Dr. Debra Patt, a breast medical oncologist from Texas Oncology, as she shares insights on the transformative impact of AI in healthcare. Discover how AI tools enhance cancer diagnostics and automate clinical documentation, significantly reducing physician workloads. Learn about AI-powered scribe services that allow for real-time patient notes and improve communication. Additionally, the discussion touches on AI's crucial role in drug discovery and optimizing clinical trials, reshaping patient care for the better.